| Clinicopathological characteristics | | Total | MGAT1 expression | P-value |
|---|
| n = 50 | High (n = 38) | Low (n = 12) |
|---|
| Age (years) | | | 72.5 ± 1.3 | 71.3 ± 2.0 | 0.459 |
| Sex | Male | 38 | 31 | 7 | 0.100 |
| Female | 12 | 7 | 5 | |
| Number of tumor | | | 1.7 ± 0.3 | 1.3 ± 0.3 | 0.176 |
| Tumor size (mm) | | | 45.3 ± 3.7 | 59.7 ± 7.9 | 0.086 |
| Intrahepatic metastasis | – | 40 | 33 | 7 | 0.031* |
| + | 10 | 5 | 5 | |
| Portal vein invasion | – | 43 | 34 | 9 | 0.208 |
| + | 7 | 4 | 3 | |
| Venous invasion | – | 40 | 31 | 9 | 0.619 |
| + | 10 | 7 | 3 | |
| Arterial invasion | – | 49 | 37 | 12 | 0.570 |
| + | 1 | 1 | 0 | |
| Biliary invasion | – | 49 | 37 | 12 | 0.570 |
| + | 1 | 1 | 0 | |
| Capsule invasion | – | 26 | 21 | 5 | 0.411 |
| + | 24 | 17 | 7 | |
| Serosal invasion | – | 41 | 33 | 8 | 0.113 |
| + | 9 | 5 | 4 | |
| Milan criteria | Within | 27 | 20 | 7 | 1.000 |
| Beyond | 23 | 18 | 5 | |
| Recurrence | – | 26 | 8 | 5 | 0.256 |
| + | 24 | 30 | 7 | |
| Death | – | 41 | 26 | 6 | 0.309 |
| + | 9 | 12 | 6 | |
- Mean ± SEM, *P < 0.05 (statistically significant)
